Economic impact of a more extensive use of FENO testing on the Italian population with asthma

Economic impact of a more extensive use of FENO testing on the Italian population with asthma

Abstract Background Asthma is a common chronic inflammatory airway affecting over 260 million people worldwide, and characterized, in the large majority of cases, by the so-called “type 2 inflammation”. Fractional exhaled nitric oxide (FENO) testing is noninvasive point-of-care tool to assess type 2...

Full description

Bibliographic Details
Main Authors: Carla Rognoni, Carlo Milano, Enrico Heffler, Matteo Bonini, Luisa Brussino, Giovanna Elisiana Carpagnano, Fabio Luigi Massimo Ricciardolo, Francesco Costa, Patrizio Armeni
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Respiratory Research
Subjects:
Fractional exhaled nitric oxide testing
Cost of illness
Asthma
Burden
Online Access:https://doi.org/10.1186/s12931-023-02437-y

Internet

https://doi.org/10.1186/s12931-023-02437-y

Similar Items